Makoto Takizawa

Pioglitazone improves insulin secretory capacity and prevents the loss of β-cell mass in obese diabetic db/db mice: possible protection of β cells from oxidative stress

Hitoshi Ishida, Makoto Takizawa, Sachihiko Ozawa et al. · Metabolism · 2004 · 139 citations

Obesity, Metabolic Syndrome, Insulin Signaling +15

Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density

Kiyoshi Suzuki, Takeshi Kurose, Makoto Takizawa et al. · Diabetes Research and Clinical Practice · 2004 · 83 citations

Metabolic Syndrome, Urology, Metabolic Bone Disease +12

Salmon Calcitonin Prevents Cyclosporin-A-Induced High Turnover Bone Loss*

Barry Stein, Makoto Takizawa, Ian Katz et al. · Endocrinology · 1991 · 77 citations

Animal Physiology, Salmon Calcitonin, Bone Health +12

Cyclosporin-A Increases Synthesis of 1,25-Dihydroxyvitamin D₃in the Rat and Mouse*

Barry Stein, B. P. Halloran, Timothy A. Reinhardt et al. · Endocrinology · 1991 · 70 citations

PPAR-γ overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein

Eisuke Ito, Sachihiko Ozawa, Kazuto Takahashi et al. · Biochemical and Biophysical Research Communications · 2004 · 48 citations

Molecular Physiology, Signal Transduction, Insulin Management +11